A Bengaluru startup backed by Infosys is harnessing the power of genomics and AI to conquer cancer.

4baseCare is a Bengaluru-based oncology precision startup founded in 2018 by Hitesh Goswami and Kshitij Rishi. The company aims to introduce a targeted approach to treating oncology patients in India, similar to the Western approach that uses genome research to understand the exact type of cancer and administer targeted therapy. 4baseCare has received funding from investors like Infosys Innovation Fund and Yali Capital, and has partnered with hospital chains like Apollo Hospitals and Fortis Healthcare. The startup uses artificial intelligence (AI) to analyze data and provide personalized treatment plans, and is working on a novel concept called the “CG Twin”, which integrates a patient’s clinical and genomic data to enable more informed treatment plans. The CG Twin is being tested by doctors and is expected to be released soon. Despite facing funding struggles, 4baseCare has made significant progress, having conducted over 15,000 tests and developing a machine learning algorithm to build the twin model. The startup’s mission is to provide evidence-based and outcome-based treatment plans, and its team is motivated by the profound impact its work has on cancer patients.